RxDoctor Payments DataLook up a doctor →

Jatinder Pruthi, MD

Gastroenterology · Lancaster, CANPI 1205852985

Payments from drug & device makers

$4,441,830in general payments, 2019–2025

Across 2,372 payments — averaging $1872.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$891K
  • Janssen Research & Development, LLC$501K
  • Bristol Myers Squibb$459K
  • Eli Lilly$404K
  • Pfizer$399K
  • Boehringer Ingelheim International GmbH$355K
  • plus $1.4M from 47 others
$16,857in research payments, 2019–2025

Across 20 payments — averaging $842.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$13K
  • Bausch Health US, LLC$2K
  • Gilead$1000

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)548$891,357
Janssen Research & Development, LLC128$501,488
Bristol Myers Squibb72$458,600
Eli Lilly38$403,599
Pfizer(2 entities)224$399,315
Boehringer Ingelheim International GmbH245$355,056
Genentech, Inc.35$288,075
AstraZeneca16$147,848
Takeda Pharmaceuticals U.S.A., Inc.99$130,173
Sanofi US Services Inc.17$129,711
E.r. Squibb & Sons, L.L.C.13$117,764
Gilead100$94,634
Ironwood Pharmaceuticals, Inc58$89,645
Bausch Health US, LLC53$71,358
Sanofi29$66,599
Regeneron17$63,854
F. Hoffmann-la Roche AG18$54,889
Novo Nordisk AS134$42,933
Phathom Pharmaceuticals, Inc.53$29,677
Ipsen Bioscience Inc.17$19,475
Shire North American Group Inc6$18,807
Ferring Pharmaceuticals AS1$17,500
Dova Pharmaceuticals7$10,151
Merck22$9,870
Adare Pharmaceuticals, Inc.1$7,800
Redhill Biopharma Inc.31$7,048
Mirum Pharmaceuticals, Inc.5$3,592
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC101$3,509
Ardelyx, Inc.46$2,128
Johnson & Johnson109$1,755
Madrigal Pharmaceuticals17$544
Boehringer Ingelheim RCV GmbH & Co KG1$487
Aimmune Therapeutics, Inc.24$412
Endogastric Solutions, Inc8$382
Lilly USA, LLC17$361
Regeneron Healthcare Solutions, Inc.14$352
Intercept Pharmaceuticals, Inc.9$183
Daiichi Sankyo Inc.7$135
Nestle Healthcare Nutrition Inc.7$113
Evoke Pharma, Inc.5$112
Boston Scientific1$95
Covidien LP2$80
Braintree Laboratories, Inc.2$79
Shionogi Inc4$61
Concordia Pharmaceuticals Inc.2$35
Blueprint Medicines Corporation1$34
Novo Nordisk1$32
Ipsen Biopharmaceuticals, Inc1$28
Echosens North America, Inc.2$26
Capsovision, Inc.1$19
Vertex1$19
Fresenius Kabi USA, LLC1$15
Alfasigma USA, Inc.1$14

How this compares

$4,441,830 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024
$781,696
Medicare patients
1,384
Services billed
7,380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Lancaster

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →